0001213900-11-006482.txt : 20111202
0001213900-11-006482.hdr.sgml : 20111202
20111202160834
ACCESSION NUMBER: 0001213900-11-006482
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20111201
FILED AS OF DATE: 20111202
DATE AS OF CHANGE: 20111202
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: SOLIGENIX, INC.
CENTRAL INDEX KEY: 0000812796
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 411505029
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 29 EMMONS DRIVE
STREET 2: SUITE C-10
CITY: PRINCETON
STATE: NJ
ZIP: 08540
BUSINESS PHONE: 609-538-8200
MAIL ADDRESS:
STREET 1: 29 EMMONS DRIVE
STREET 2: SUITE C-10
CITY: PRINCETON
STATE: NJ
ZIP: 08540
FORMER COMPANY:
FORMER CONFORMED NAME: DOR BIOPHARMA INC
DATE OF NAME CHANGE: 20020329
FORMER COMPANY:
FORMER CONFORMED NAME: ENDOREX CORP
DATE OF NAME CHANGE: 19960916
FORMER COMPANY:
FORMER CONFORMED NAME: IMMUNOTHERAPEUTICS INC
DATE OF NAME CHANGE: 19920703
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: MYRIANTHOPOULOS EVAN
CENTRAL INDEX KEY: 0001050955
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-16929
FILM NUMBER: 111240486
MAIL ADDRESS:
STREET 1: 29 EMMONS DRIVE
STREET 2: SUITE C-10
CITY: PRINCETON
STATE: NJ
ZIP: 08540
4
1
f4120111myrian_soligenix.xml
OWNERSHIP DOCUMENT
X0304
4
2011-12-01
0
0000812796
SOLIGENIX, INC.
SNGX
0001050955
MYRIANTHOPOULOS EVAN
29 EMMONS DRIVE, SUITE C-10
PRINCETON
NJ
08540
1
1
0
0
Sr VP and CFO
Stock Option (Right to Buy)
0.032
2011-12-01
4
A
0
1200000
0
A
2011-12-01
2021-11-30
Common Stock
1200000
1200000
D
The option vests immediately as to 300,000 shares and vests as to the remainder of the shares on each three (3) month anniversary of December 1, 2011 at a rate of 75,000 shares per quarter thereafter. The exercise price of the option equals $0.032 per share, the market price of the Company's common stock as of the close of business on December 1, 2011.
/s/ Evan Myrianthopoulos
2011-12-02